D. Páez López-Bravo

Author

D. Páez López-Bravo

Also Known As

D. López-Bravo, D. Páez López-Bravo, David P. Lopez-Bravo, David Paez Lopez-Bravo, David Paez López-Bravo, David Páez Lopez-Bravo, David Páez López-Bravo

Publications

385

Citations

H-Index

Concepts

All Affiliations

Hospital de Sant Pau Fondazione IRCCS Istituto Nazionale dei Tumori Instituto Nacional de Cancerología National Hospital Organization Kyushu Cancer Center University of Ulsan

About

D. Páez López-Bravo is an author at Hospital de Sant Pau specializing in oncology, medicine, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	49
2	Public Health	1	1	13
3	Biostatistics	1	1	13
4	Diagnostic Sciences	1	1	13
5	Epidemiology	1	1	13

D. Páez López-Bravo

Publications

369

Citations

H-Index

Page 1

	Year	Citations
Sotorasib plus Panitumumab in Refractory Colorectal Cancer with Mutated <i>KRAS</i> G12C Marwan Fakih, Lisa Salvatore, Taito Esaki, New England Journal of Medicine	2023	294
Brain metastases in colorectal cancer: prognostic factors and survival analysis L.P. del Carpio, A.C. Virgili Manrique, Justyna Szafranska, International Journal of Colorectal Disease Neuro-oncologyBrain MetastasesGastrointestinal OncologyMedicinePathology	2018	19
Retifanlimab in Advanced Penile Squamous Cell Carcinoma: The Phase 2 ORPHEUS Study Xavier García del Muro, D. Páez López-Bravo, Miler Andrés Cuéllar-Rivas, European Urology Oncology UrologyGenitourinary CancerMedicineOrpheus StudyPathology	2024	17
Overall Survival Analysis of the Phase III CodeBreaK 300 Study of Sotorasib Plus Panitumumab Versus Investigator's Choice in Chemorefractory <i>KRAS</i> G12C Colorectal Cancer Filippo Pietrantonio, Lisa Salvatore, Taito Esaki, Journal of Clinical Oncology	2025	16
Overall survival (OS) of phase 3 CodeBreaK 300 study of sotorasib plus panitumumab (soto+pani) versus investigator’s choice of therapy for <i>KRAS</i> G12C-mutated metastatic colorectal cancer (mCRC). Marwan Fakih, Lisa Salvatore, Taito Esaki, Journal of Clinical Oncology Clinical EndpointPrognosisClinical SpecialtiesPathologyPopulation Health Sciences	2024	13
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer Alessandro Audisio, Chiara Gallio, Vaneja Velenik, JAMA Oncology	2025	10

Page 1